Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment.

ABSTRACT:

Background

Statins taken for cardiovascular indications by patients with breast cancer and lymphoma during doxorubicin treatment may attenuate left ventricular ejection fraction (LVEF) decline, but the effect of statins on LVEF among patients with no cardiovascular indications is unknown.

Methods

A double-blind, placebo-controlled, 24-month randomized trial of 40 mg of atorvastatin per day administered to patients with breast cancer and lymphoma receiving doxorubicin was conducted within the National Cancer Institute Community Oncology Research Program across 31 sites in the United States. At pretreatment and then 6 and 24 months after initiating doxorubicin, we assessed left ventricular (LV) volumes, strain, mass, and LVEF through cardiac magnetic resonance imaging, along w

SUBMITTER: Hundley WG 

PROVIDER: S-EPMC9997095 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature